Trimas Corporation · NASDAQ:TRS

Trimas — Q1 2026 Earnings Presentation

20 slides from Trimas's earnings presentation, Apr 30, 2026

  1. Slide 1: First Quarter 2026 Earnings Presentation

    First Quarter 2026 Earnings Presentation April 30, 2026

  2. Slide 2: Disclaimer

    Disclaimer Forward-Looking Statements Any "forward-looking" statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, contained herein, including those relating to TriMas’ business, financial condition or future results, invol

  3. Slide 3: Opening Remarks

    Opening Remarks Q1 2026: Executing the Plan Successfully Closed the TriMas Aerospace Divestiture on March 16, 2026  Generated approximately $1.24 billion of net after-tax cash proceeds  Repaid borrowings under the revolving credit facility related to Q4 share repurchase activity  Repurchased addi

  4. Slide 4: First Quarter 2026 Results – Continuing Operations

    First Quarter 2026 Results – Continuing Operations Net Sales Segment Operating Profit (in millions) Operating Profit (1) (in millions) (in millions) $168.3 Q1 2026 Results +10.4% $152.5  Strong year-over-year sales growth $20.5 +14.6% $12.7 +32.2% driven by organic volume gains and $17.9 $9.6 Organ

  5. Slide 5: Balance Sheet & Capitalization

    Balance Sheet & Capitalization Net Cash Position Provides Future Financial Flexibility  Strong balance sheet following the TriMas Aerospace divestiture, with a net cash position of $913 million March 31, December 31, March 31, Key Credit Statistics 2026 2025 2025  Cash currently invested in intere

  6. Slide 6: Segment Overview: Packaging

    Segment Overview: Packaging Adjusted for Special Items Q1 2026 Q1 2025 Change Q4 2025 Net Sales $139.2 $127.6 9.1% $129.3 Operating Profit $17.7 $17.8 -0.8% $15.0 Operating Margin 12.7% 14.0% -130 b ps 11.6% (1) Adjusted EBITDA $25.5 $26.2 -2.7% $21.5 Adjusted EBITDA Margin 18.3% 20.5% -220 b ps 16.

  7. Slide 7: Segment Overview: Specialty Products

    Segment Overview: Specialty Products Adjusted for Special Items Q1 2026 Q1 2025 Change Q4 2025 Net Sales $29.1 $24.9 17.0% $26.2 Operating Profit $2.9 $0.1 n/m $1.7 Operating Margin 9.8% 0.4% 940 b ps 6.5% (1) Adjusted EBITDA $3.6 $0.9 291.3% $2.4 Adjusted EBITDA Margin 12.4% 3.7% 870 b ps 9.1% Take

  8. Slide 8: Forward Expectations – from Continuing Operations

    Forward Expectations – from Continuing Operations As of April 30, 2026 Full Year 2026 Outlook SALES GROWTH ADJUSTED OPERATING PROFIT ADJUSTED EPS(1) 3% to 6% MARGIN $1.50 to $1.70 IMPROVEMENT (2025: $645.7M) 300+ BPS (2025: $0.55) (2025: 5.3%) Full Year 2026 Assumptions  Margin expansion driven pri

  9. Slide 9: Levers for Long-term Value Creation

    Levers for Long-term Value Creation Continuous Improvement Innovation Capital Allocation Portfolio Shaping • Accelerate customer-driven • Pursue strategic, high-quality • Focus on highest-value products and • Embed Operational Excellence through Lean, Six Sigma and product innovation to address acqu

  10. Slide 10: Q&A

    Q&A

  11. Slide 11: Appendix

    — Appendix

  12. Slide 12: Level-Setting RemainCo (Continuing Operations)

    Level-Setting RemainCo (Continuing Operations) Full Year 2025 Basis ($ in millions, except per share amount) Packaging $ % of Sales Packaging 2026 Focus Areas Net Sales $535.5 • Streamline commercial and operational functions to reduce complexity and cost, unify brands, and further integrate prior a

  13. Slide 13: Condensed Consolidated Balance Sheet

    Condensed Consolidated Balance Sheet March 31, December 31, 2026 2025 Assets Current assets: Cash and cash equivalents $ 1,309,610 $ 30,020 Receivables, net 128,610 111,270 Inventories 117,270 108,720 Prepaid expenses and other current assets 34,450 36,380 Current assets, discontinued operations - 1

  14. Slide 14: Consolidated Statement of Income

    Consolidated Statement of Income Three months ended March 31, 2026 2025 Net sales $ 168,280 $ 152,460 Cost of sales (131,410) (119,630) Gross profit 36,870 32,830 Selling, general and administrative expenses (29,990) (30,970) Net gain on dispositions of assets 10 5,290 Operating profit 6,890 7,150 O

  15. Slide 15: Consolidated Statement of Cash Flows

    Consolidated Statement of Cash Flows Three months ended March 31, 2026 2025 Cash Flows from Operating Activities: Income (loss) from continuing operations (51,760) 1,940 Income from discontinued operations 852,590 10,480 Net income 800,830 12,420 Adjustments to reconcile net income to net cash provi

  16. Slide 16: Company and Segment Financial Information

    Company and Segment Financial Information Continuing Operations Three months ended Three months ended March 31, March 31, 2026 2025 2026 2025 Packaging Adjusted operating profit, continuing operations $ 12,700 $ 9,610 Net sales $ 139,170 $ 127,570 Corporate operating expenses (adjusted) 5,120 7,120

  17. Slide 17: Additional Information on Non-GAAP Measures

    Additional Information on Non-GAAP Measures Continuing Operations Three months ended March 31, 2026 2025 Income (loss) from continuing operations, as reported $ (51,760) $ 1,940 Special Items to consider in evaluating quality of net income from continuing operations: Business restructuring and sever

  18. Slide 18: Additional Information on Non-GAAP Measures

    Additional Information on Non-GAAP Measures Continuing Operations Three months ended March 31, 2026 2025 As reported Special Items As adjusted As reported Special Items As adjusted Net cash provided by (used for) operating activities $ (19,050) $ 5,340 $ (13,710) $ 6,990 $ 4,390 $ 11,380 Less: Capit

  19. Slide 19: Additional Information on Non-GAAP Measures

    Additional Information on Non-GAAP Measures Continuing Operations Three months ended Twelve months ended March 31, March 31, From Continuing Operations 2026 2025 2026 2025 Income (loss) from continuing operations, as reported $ (51,760) $ 1,940 $ 18,610 $ - Depreciation expense 8,190 7,640 32,080 39

  20. Slide 20: Additional Information on Non-GAAP Measures

    Additional Information on Non-GAAP Measures As of April 30, 2026 Full Year 2026 GAAP to Non-GAAP EPS Outlook Reconciliation Twelve months ended December 31, 2026 Continuing Operations Low High Diluted earnings per share (GAAP) $ (0.34) $ (0.14) Pre-tax amortization of acquisition-related intangible

TriMas — Q1 2026 Earnings Presentation on 6ix